Boston Scientific Corp. (NYSE: BSX) will pay a premium of approximately $210 million in cash to acquire EndoChoice Holdings Inc. (NYSE: GI). Shares of Boston Scientific eased a penny to close at $23.72 while EndoChoice Holdings stock surged $3.73 to close at $7.95.
Boston Scientific buys EndoChoice Holdings
September 27, 2016 at 18:48 PM EDT